Oshi, M., Newman, S., Murthy, V., Tokumaru, Y., Yan, L., Matsuyama, R., . . . Takabe, K. (2020). ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer. Cancers (Basel).
Chicago Style CitationOshi, Masanori, Stephanie Newman, Vijayashree Murthy, Yoshihisa Tokumaru, Li Yan, Ryusei Matsuyama, Itaru Endo, i Kazuaki Takabe. "ITPKC As a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer." Cancers (Basel) 2020.
Cita MLAOshi, Masanori, et al. "ITPKC As a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer." Cancers (Basel) 2020.
Atenció: Aquestes cites poden no estar 100% correctes.